• Practical Guide to 0.4% Trypan Blue Solution in Cell Viabili

  2026-06-08

  0.4% Trypan Blue Solution is an azo dye for cell staining, providing researchers a rapid and reliable method for distinguishing viable from non-viable cells in cell counting and viability measurement workflows. It is intended strictly for research use, not for diagnostic or clinical applications, and should be integrated with established laboratory protocols for optimal results.

• Liproxstatin-1 HCl: Advanced Ferroptosis Inhibition Workflow

  2026-06-07

  Liproxstatin-1 HCl empowers researchers to dissect ferroptosis with nanomolar precision and robust selectivity, enabling reproducible results even in challenging in vitro and in vivo models. Its high solubility and selectivity streamline complex workflows and unlock new avenues in acute renal and hepatic injury research.

• CCCP in Mitochondrial Research: Protocols, Pitfalls, and Inn

  2026-06-06

  Leveraging CCCP (carbonyl cyanide m-chlorophenyl hydrazine) enables precise modeling of mitochondrial dysfunction and energy disruption in live-cell assays. This guide translates recent advances in deep learning-based mitochondrial imaging and outlines best-practice workflows, troubleshooting strategies, and the impact of APExBIO’s high-purity CCCP in translational neurodegenerative research.

• 3D Organoid–Fibroblast Co-Culture Models PDAC Chemoresistanc

  2026-06-05

  Schuth et al. introduce a patient-specific three-dimensional (3D) co-culture system combining pancreatic tumor organoids with matched cancer-associated fibroblasts (CAFs), enabling direct investigation of stroma-mediated chemoresistance in pancreatic ductal adenocarcinoma (PDAC). This platform advances preclinical modeling by revealing how CAF-induced epithelial-to-mesenchymal transition (EMT) contributes to reduced drug sensitivity, with clear implications for personalized therapy design and drug screening.

• Bsa I (RNase-free): Technical Guidance for DNA Cleavage Work

  2026-06-05

  Bsa I (RNase-free) provides precise DNA cleavage for molecular biology research, particularly in workflows where RNA preservation is critical, such as gene cloning and recombinant DNA technology. It is not suitable for diagnostic or clinical use and should be reserved for sensitive nucleic acid manipulations requiring RNase-free conditions.

• ECL Chemiluminescent Substrate Detection Kit: Mechanistic In

  2026-06-04

  Explore how the ECL Chemiluminescent Substrate Detection Kit enables ultrasensitive immunodetection and how recent multi-omics research refines assay strategies. This article offers a mechanistic deep dive and protocol guidance beyond standard Western blot workflows.

• PreScission Protease: Precision Tag Cleavage for Protein Pur

  2026-06-04

  PreScission Protease (PSP) leverages HRV 3C protease specificity to deliver highly efficient fusion tag removal, even at low temperatures, ensuring native protein recovery for advanced molecular workflows. Discover how this APExBIO enzyme outperforms traditional tag cleavage tools in applications ranging from condensate biology to disease modeling.

• Nuclear Condensate Assembly by Drosophila Keap1 in Oxidative

  2026-06-03

  This study uncovers that Drosophila Keap1 (dKeap1) proteins form nuclear condensates in response to oxidative stress, revealing a novel phase separation-driven mechanism underlying Keap1’s nuclear functions. These findings provide important mechanistic insights into how the Keap1-Nrf2 pathway integrates stress response with chromatin regulation and developmental gene control.

• Parathyroid hormone (1-34) (human) in Bone and CKD Models

  2026-06-03

  Parathyroid hormone (1-34) (human) empowers researchers to precisely dissect calcium regulation and bone metabolism in both osteoporosis and chronic kidney disease models. This guide delivers protocol-ready parameters and advanced troubleshooting tips, drawing on the latest mechanistic insights into PTH-driven pathology and innovative cardiovascular applications.

• AP-2α Reduces TMZ Resistance in Recurrent GBM by Targeting M

  2026-06-02

  This study demonstrates that the transcription factor AP-2α directly downregulates MGMT expression, overcoming temozolomide (TMZ) resistance in recurrent glioblastoma (GBM). The findings highlight a mechanistic link between AP-2α, MGMT inhibition, and enhanced DNA damage, offering new avenues for sensitizing resistant tumors to alkylating agents.

• Reactive Oxygen Species Assay Kit: Precision in Oxidative St

  2026-06-02

  Accelerate oxidative stress and apoptosis research with the Reactive Oxygen Species Assay Kit (DHE), featuring robust detection of intracellular superoxide anion via the dihydroethidium probe. This workflow-centric guide dissects advanced application scenarios, key troubleshooting strategies, and protocol enhancements for reliable, quantitative ROS measurement in living cells.

• Vernakalant Hydrochloride: Ion Channel Blockade for Rapid AF

  2026-06-01

  Vernakalant Hydrochloride (RSD1235) stands out as an atrial-selective antiarrhythmic agent engineered for rapid conversion of atrial fibrillation, targeting multiple ion channels with precision. Explore robust workflow enhancements, troubleshooting strategies, and translational applications that set this compound apart for both in vitro and in vivo cardiac research.

• Jasplakinolide: Elite Actin Polymerization Inducer in Cell R

  2026-06-01

  Jasplakinolide, sourced from APExBIO, stands at the forefront of actin cytoskeleton research—enabling high-fidelity, reproducible manipulation of actin dynamics for advanced cell biology, antifungal, and cytotoxicity studies. This guide delivers evidence-backed workflows, troubleshooting strategies, and lessons from chemical genetics to unlock the full experimental potential of this actin polymerization inducer.

• Dual Glutamate Receptor Blockade Reduces Soman-Induced Neuro

  2026-05-31

  The reference study demonstrates that IEM-1925, a dual AMPA/NMDA receptor antagonist, provides superior seizure suppression, neuroprotection, and cognitive benefit in a rat model of soman-induced status epilepticus. These findings highlight the translational potential of targeted glutamate receptor blockade for mitigating organophosphorus nerve agent (OPNA) neurotoxicity and inform best practices for preclinical neuroprotection and excitotoxicity research.

• 2-Deoxy-D-glucose: Applied Glycolysis Inhibition in Research

  2026-05-30

  2-Deoxy-D-glucose (2-DG) is revolutionizing metabolic research as a precision glycolysis inhibitor, enabling targeted investigation of cancer, viral, and bone metabolism. This article delivers actionable workflows, advanced troubleshooting, and research-backed use-cases rooted in recent breakthroughs. Discover practical protocol enhancements and the latest insights for leveraging 2-DG in your lab.

16527 records 2/1102 page Previous Next 12345 下5页 Last page